In this Applied Clinical Trials article, Aman Khera and Jeff Trotter discuss the road ahead following the U.S. Food and Drug Administration’s (FDA) draft guidance released in September 2021 – and what it means for real-world data (RWD) and real-world evidence (RWE).
Reviewing FDA’s Latest Guidance on RWD
